Notice Pursuant to the National Cooperative Research and Production Act of 1993-Rapid Response Partnership Vehicle

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division Notice is hereby given that, on January 5, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Rapid Response Partnership Vehicle (“RRPV”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to section 6(b) of the Act, the identities of the parties to the venture as of the date of this filing are: AATec Medical GmbH, München, GERMANY; ASELL LLC, Owings Mills, MD; Access to Advanced Health Institute, Seattle, WA; Adaptive Phage Therapeutics, Inc., Gaithersburg, MD; Advanced BioScience Laboratories, Inc., Rockville, MD; Aerium Therapeutics, Inc., Boston, MA; Alamgir Research, Inc. dba ARIScience, Wayland, MA; Alchem Laboratories Corp., Alachua, FL; Alentic Microscience, Inc., Halifax, Nova Scotia, CANADA; Altec, Inc., Natick, MA; Antiviral Technologies LLC, Dallas, TX; ApiJect Systems America, Inc., Stamford, CT; Applied Materials, Inc., Santa Clara, CA; Apriori Bio, Inc., Cambridge, MA; Aridis Pharmaceuticals, Inc., Los Gatos, CA; AstraZeneca Pharmaceuticals LP, Wilmington, DE; Atea Pharmac…